Redx Pharma PLC (LSE:REDX) - Share price - Overview

Stock Report

Redx Pharma PLC REDX

Last Price
GBX32.38

Day Change
-0.50|-1.52%

As of 24/05/2017
12:44:42 BST | GBX
Minimum 15 Minutes Delay.

Last Close32.88p
Day Range31.80 - 33.00
Mkt Cap40.95Mil
52-Wk Range23.00 - 67.80
Yield %0.00
ISINGB00BSNB6S51
Volume17,701
P/E-1.70
P/SInfinity
P/CF-2.03

Share Price

Total Returns 23/06/2017

 Chg (%)  
More ...
Redx Pharma PLC-1.52 
FTSE 100 TR GBP-0.50
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-4.01-9.43-14.95
Net Profit-3.35-8.18-15.52
Reported EPS-5.16-14.10-19.80
Balance Sheet
Current Assets6.4412.347.95
Non Current Assets0.441.411.45
Total Assets7.0613.769.40
Current Liabilities5.244.067.68
Total Liabilities5.246.067.68
Total Equity1.827.701.72
Cash Flow
Operating Cash Flow-2.57-6.65-13.29
Net Change in Cash1.866.54-3.68
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-8.96-8.62--3.76---
2018-0.34-0.32--100.56---

Company Profile

Redx Pharma PLC through its subsidiaries is a drug discovery and development company. The Company develops proprietary, small molecule therapeutics to address areas of unmet medical need principally in two areas, cancer and infectious disease.

Sector

Biotechnology

Market Position

1161 of 1843 Companies

Index

Outlook

(17/05/2017) "The company remains well positioned to secure value from its assets, including securing further commercial partnerships, and to further develop the business"

Next Event 30/09/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-12.5915.5116.74
Div Yld (E)0.003.544.17
PEG (E)0.000.460.95
ROCE-425.24190.29209.95
Op Mrgn0.00-3.24-100.19
EPS Grwth0.0045.3233.33
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Iain Ross
Chief Executive OfficerDr. Neil Murray
Finance Director (Interim)Andrew Booth
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.